New Treatment Approved for Haemophilia A and B in Patients 12
Treatment for haemophilia patients: The Medicines and Healthcare products Regulatory Agency (MHRA) has granted approval for the medicine marstacimab (Hympavzi) to prevent or reduce bleeding in patients aged 12 years and above, weighing…
